Welcome to BioMarket Group!

Analytical Tool - Cancer Immunotherapy

Additional Information

Published Date Mar 25, 2014
Pages No
License Prices No
PDF Fact Sheet No
Format PDF & Desktop App plus Online Access to Updates (One Year)
Publisher BioSeeker Group

Availability: In stock

$8,175.00

Quick Overview

A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer immunotherapy.
Request free sample pages from Analytical Tool - Cancer Immunotherapy

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are three products already appreciated by many of our customers:

The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in
    immunotherapy drug development in oncology
  • Information on key industry related
    immunotherapy drug projects in oncology
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

 

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of
    immunotherapy drugs in oncology
  • Identifying emerging cancer immunotherapy products & key areas of pharmaceutical R&D
 

*This software application is a searchable database reflects the most recent advances in the field of immunotherapy drug development in cancer, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.



License Prices:

Request free sample pages from Analytical Tool - Cancer Immunotherapy

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Cancer Vaccines
The ultimate tool for serious players who would like to understand the current competitive field in cancer vaccine development. Learn More


Analytical Tool - Apoptosis in Oncology
In this Analytical Tool, BioSeeker Group brings light and understanding of the whole industrial endeavor in apoptosis as cancer therapeutic mechanism. Learn More

Other selected research from the 'Oncology' category:


Analytical Tool - Prostate Cancer
A unique tool for analyzing the complex competitive pressure within the field of prostate cancer. Learn More


IL-7 Signaling Pathway in Oncology Drug Pipeline Update
BioSeeker Group have identified 90 companies plus partners who are today developing 95 IL-7 pathway targeting drugs in 389 developmental projects in cancer across 85 different targets. In addition, there is 1 suspended drug and another 36 drugs where development has been ceased. Learn More

Other selected research from the 'Immunomodulators' category:


Antibodies in Oncology Drug Pipeline Update
BioSeeker Group have identified 542 companies plus partners who are today developing 1308 antibody drugs in 3051 developmental projects in cancer across 414 different targets. In addition, there are 4 suspended drugs and another 407 drugs where development has been ceased. Learn More


Immunotherapy in Oncology Drug Pipeline Update
BioSeeker Group have identified 830 companies plus partners who are today developing 1578 cancer immunotherapy drugs in 4062 developmental projects in cancer across 535 different targets. In addition, there are 19 suspended drugs and another 624 drugs where development has been ceased. Learn More